Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case–Control Study
This study shows a decrease in plasminogen in patients during hepatitis. It suggests it is an important element to evaluate the thrombotic risk although the exploration of other coagulation tests should be associated with it for a complete and exhaustive evaluation and a better final diagnosis.
Authors
- Romaric De Manfouo Tuono (ORCID: https://orcid.org/0000-0002-2867-0538)
- Simon Ngamli Fewou (ORCID: https://orcid.org/0000-0002-7150-8771)
- Marius Mbiandjeu Tchoumke (ORCID: https://orcid.org/0000-0003-3394-6137)
- Winy Asdrid Djoumeni Tepe
- Winnie Ketcha Jeuta
Institutions
- Université de Yaoundé I (CM)
- Université des Montagnes (CM)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1002/hsr2.70648
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00